Yunxiang Sun

Mr. Yunxiang Sun

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Cancer
Verified
Journal Article
Open access
RLRixin Li
Rixin Li
BLBin Liu
Bin Liu
YLYumei Liu
Yumei Liu
YLYang Liu
Yang Liu
YHYang He
Yang He
Qiong YuQiong Yu
Qiong Yu
Objective: To investigate the association between serum lipid levels in patients with primary non-small cell lung cancer and the risk of developing metastases, a retrospective cohort-based nested case-control study was conducted.

28 February 2024 in General Psychiatry
Verified
Journal Article
Open access
PDF file
YSYunxiang Sun
Yunxiang Sun
SPSoim Park
Soim Park
AMAbid Malik
Abid Malik
NANajia Atif
Najia Atif
AZAhmed Zaidi
Ahmed Zaidi
Pamela J. SurkanPamela J. Surkan
Pamela J. Surkan
Background Little is known about the association between stressors (especially positive stressors) during pregnancy and postpartum depression and anxiety. Aims We investigated the association between positive and negative stress events during different stages of pregnancy and postpartum mental health outcomes among low-income pregnant women with symptoms of anxiety in Pakistan and evaluated whether an intervention based on cognitive–behavioural therapy (CBT) had a regulatory effect. Methods Participants were 621 pregnant Pakistani women with mild anxiety. Using the Pregnancy Experience Scale-Brief Version, six scores were created to assess positive and negative stressors. We performed a multivariate linear regression to examine whether these six scores, measured both at baseline and in the third trimester, were associated with postpartum anxiety and depressive symptoms. The effect of the intervention on this relationship was examined by adding an interaction term to the regression model. Results Hassles frequency measured in the third trimester was positively associated with depression (B=0.22, 95% confidence interval (CI): 0.09 to 0.36) and anxiety (B=0.19, 95% CI: 0.08to 0.30). At the same timepoint, uplifts intensity was negatively associated with symptoms of depression (B=−0.82, 95% CI: −1.46 to –0.18) and anxiety (B=−0.70, 95% CI: −1.25 to –0.15), whereas hassles intensity was positively related to symptoms of depression (B=1.02, 95% CI: 0.36 to 1.67) and anxiety (B=0.90, 95% CI: 0.34 to 1.47). The intensity ratio of hassles to uplifts reported in the third trimester was positively related to both depression (B=1.40, 95% CI: 0.59 to 2.20) and anxiety (B=1.26, 95% CI: 0.57 to 1.96). The intervention strengthened the overall positive effects of uplifts and the negative effects of hassles. Pregnancy experiences at baseline during early pregnancy to mid-pregnancy were not associated with mental health outcomes. Conclusions Stressors in the third trimester but not earlier in pregnancy were associated with postpartum symptoms of anxiety and depression. The CBT intervention modified the association between pregnancy stressors and postpartum mental health outcomes. Programmes that promote positive experiences and reduce negative experiences, especially in late pregnancy, may mitigate postpartum mental health consequences. Trial registration number NCT03880032.

4 November 2022 in Environmental Toxicology
Verified
Journal Article
Closed access
XZXiayu Zhang
Xiayu Zhang
HHHuifang Hao
Huifang Hao
KMKai Ma
Kai Ma
HPHuan Pang
Huan Pang
XLXinyue Li
Xinyue Li
MJMinghua Jin
Minghua Jin

1 September 2025 in The Cancer Journal
Verified
Journal Article
Open access
MSMariana P. Socal
Mariana P. Socal
JAJoy Acha
Joy Acha
CYChia-Yu Yang
Chia-Yu Yang
YSYunxiang Sun
Yunxiang Sun
MDMaqbool Dada
Maqbool Dada
JBJeromie Ballreich
Jeromie Ballreich
Drug shortages remain a problem in the United States, jeopardizing patient care. To help inform solutions, this study reviewed recent oncology drug shortages for causes and mitigation strategies. Using the FDA’s Drug Shortage Database, 15 oncology drugs with shortages between 2023 and 2025 were identified. Twelve drugs had shortages lasting >2 years (maximum: >13 y). Searches of PubMed and Google Scholar, online media sources, and FDA documents uncovered 9 main causes: manufacturing quality problems, limited-source dependency, regulatory bottlenecks, global over-reliance, absence of buffer stocks, demand surges, low economic incentives, active pharmaceutical ingredient shortages, and shelf-life constraints. Mitigation strategies involved 4 stakeholders: regulators (expedited regulatory action, importation, expiration extensions), manufacturers (capacity expansion), providers (dose-sparing regimens, therapeutic alternative protocols, allocation prioritization), and purchasers-distributors including GPOs (supply collaboration). Policies to mitigate drug shortages should include new approaches to identify vulnerable markets and involve multiple stakeholders. Factors identified in this study also offer pathways for shortage prevention.

31 October 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
PCPoliana Espíndola Correia
Poliana Espíndola Correia
LBLauren Bisi
Lauren Bisi
MZMinghui Zhang
Minghui Zhang
YSYunxiang Sun
Yunxiang Sun
BMBárbara B. Martins
Bárbara B. Martins
Fernando GerchmanFernando Gerchman
Fernando Gerchman
Background: Brazil’s dietary patterns and significant socioeconomic and geographic diversity present unique challenges for the prevention of cardiometabolic diseases. Methods: In this cross-sectional study, we analyzed data from a nationwide representative survey to understand how dietary patterns related to cardiometabolic diseases. We classified the dietary pattern of participants as whole plant-based, processed plant-based, and animal-based. Then, they were categorized into high, intermediate, and low consumption. Logistic regression analysis was used to test the prevalence of obesity, hypertension, hypercholesterolemia, diabetes, stroke, and heart diseases according to the level of intake of each of the three dietary patterns. Results: Compared to the low intake of a whole plant-based dietary pattern, a high intake was associated with a lower prevalence of obesity (OR 0.64; 95% CI 0.54, 0.75) and hypercholesterolemia (OR 0.69, 95% CI 0.56, 0.85). A processed plant-based dietary pattern (including items such as soda and sweets) was inversely associated with the prevalence of obesity (OR 0.90; 95% CI 0.83, 0.97), hypertension (OR 0.82; 95% CI 0.76, 0.88), hypercholesterolemia (OR 0.81; 95% CI 0.74, 0.88), and diabetes (OR 0.53; 95% CI 0.48, 0.59). A high intake of animal-based dietary patterns was associated with a lower prevalence of heart diseases (OR: 0.60; 95% CI 0.40, 0.90). Conclusions: In this cross-sectional analysis, greater adherence to specific dietary patterns was associated with differences in the prevalence of cardiometabolic conditions. However, causality cannot be established, and longitudinal studies are warranted to confirm these findings.

5 May 2025 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
MDMaqbool Dada
Maqbool Dada
TDTinglong Dai
Tinglong Dai
YSYunxiang Sun
Yunxiang Sun
MSMariana Socal
Mariana Socal
Problem definition: A commonly held belief is that tariffs on imports are directly reflected in consumer prices. However, in complex multi-stage supply chains, the actual consumer-price impact of a tariff can be diluted. This article examines how import tariffs propagate through a multi-stage supply chain and why the resulting consumer price increases are typically much smaller than the headline tariff rate. We focus on the U.S. pharmaceutical supply chain as a case in point, due to its heavy reliance on imported inputs and multiple intermediary markups. Methodology/results: We develop a tariff impact calculator to model cost build-up, markup, and partial cost absorption at each stage of the supply chain. Our analysis shows that even a substantial tariff (e.g., 25%) on an Active Pharmaceutical Ingredient (API) leads to only a minor uptick (often around 1% or less) in the final retail price of the drug. Furthermore, we find that the government’s gross tariff revenues are substantially offset by reduced corporate tax receipts and higher procurement costs for public healthcare programs. We derive a simple condition under which government net receipts from tariffs can turn negative. Managerial implications: Our discussions highlight why tariff-induced price shocks may be smaller than commonly feared, and why firms in multi-stage supply chains often opt to absorb a portion of cost increases rather than fully passing them on. For supply chain managers, understanding the muted consumer-price impact allows for better pricing and sourcing strategies during periods of trade protectionism. For policymakers, the results caution that tariffs may fail to achieve their intended objectives—such as making reshoring more competitive or raising net government revenue.